S-Condom Uterine Tamponade in Controlling Atraumatic Postpartum Haemorrhage (PPH) - RCT
Launched by MAMMS INSTITUTE OF FISTULA AND WOMENS HEALTH · Sep 26, 2022
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
A Randomized Controlled Non inferiority Trial will be conducted to see the feasibility, acceptability and efficacy of S-Condom Uterine Tamponade in women with atraumatic PPH and not responding to first line of treatment. The women will be divided randomly into two groups, in both groups two condom tied on a catheter will be introduced inside the uterus. In one group (Control group), condom will be inflated with saline and in another group(study group) it will be inflated with air. Time required to stop bleeding will be measured for comparison. Data collected will be analyzed using a quantit...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All women who presented with atraumatic postpartum hemorrhage, refractory to first-line treatment (uterine massage and oxytocin) and who will give their consent will be included in the study and will be randomized
- Exclusion Criteria:
- • Women known to have allergy to latex, or presenting with clinical chorioamnionitis or primary hemorrhage caused by cervical-vaginal lacerations, a uterine rupture, or a placenta accreta will be excluded.
About Mamms Institute Of Fistula And Womens Health
The Mamms Institute of Fistula and Women's Health is a pioneering clinical research organization dedicated to advancing the understanding and treatment of obstetric fistula and other women's health issues. With a commitment to improving health outcomes for women, the Institute conducts innovative clinical trials and research initiatives aimed at developing effective therapies and interventions. By collaborating with healthcare professionals and leveraging cutting-edge methodologies, Mamms Institute seeks to enhance the quality of care for women suffering from fistula and related conditions, while promoting education and awareness in the wider community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sayeba Akhter, Dr.
Principal Investigator
Mamms Institute of Fistula and Womens Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials